The goals of the Laboratory Cancer Research Center are to: (a) foster research in chemical carcinogenesis, particularly as it relates to nitrogen-containing organic compounds, certain chemotherapeutic agents and polycyclic aromatic hydrocarbons, (b) develop model systems for the study of the counterparts to human colon, pancreas, esophagus, prostate and lung cancers, (c) develop an understanding of the mechanisms of activation of procarcinogens and of detoxification of carcinogens and to elucidate the contributions of nutrition, environment and genetics to their regulation, (d) clarify the role of DNA repair in mutagenesis and carcinogenesis, (e) elucidate the mechanisms by which certain viruses are able to transform cells, as well as how chemical carcinogens may influence this expression, (f) develop a program in clinical and biochemical epidemiology and (g) extrapolate from the accomplishment of the above aims to understanding the human cancer problem. These areas are being met by a team of pathologists, virologists, nutritionists, pharmacologists, chemists, biochemists and cell/molecular biologists working in a collaborative manner. The cancer center is augmented by educational efforts aimed primarily at the graduate level, but also reflected in undergraduate medical and postgraduate programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA036727-06
Application #
3101784
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1984-07-01
Project End
1992-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Overall Medical
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Rana, Sandeep; Sonawane, Yogesh A; Taylor, Margaret A et al. (2018) Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorg Med Chem Lett 28:3736-3740
Azadmanesh, Jahaun; Borgstahl, Gloria E O (2018) A Review of the Catalytic Mechanism of Human Manganese Superoxide Dismutase. Antioxidants (Basel) 7:
Haney, Staci L; Chhonker, Yashpal S; Varney, Michelle L et al. (2018) Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor. Invest New Drugs 36:810-818
Chhonker, Yashpal S; Haney, Staci L; Matthiesen, Robert A et al. (2018) Quantitative determination of a potent geranylgeranyl diphosphate synthase inhibitor using LC-MS/MS: Derivatization and application. J Pharm Biomed Anal 153:22-28
Lockridge, Oksana; David, Emilie; Schopfer, Lawrence M et al. (2018) Purification of recombinant human butyrylcholinesterase on Hupresin®. J Chromatogr B Analyt Technol Biomed Life Sci 1102-1103:109-115
Saxena, Sugandha; Hayashi, Yuri; Wu, Lingyun et al. (2018) Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget 9:5931-5943
Souza, Nathália P; Hard, Gordon C; Arnold, Lora L et al. (2018) Epithelium Lining Rat Renal Papilla: Nomenclature and Association with Chronic Progressive Nephropathy (CPN). Toxicol Pathol 46:266-272
Ray, Sutapa; Coulter, Don W; Gray, Shawn D et al. (2018) Suppression of STAT3 NH2 -terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de-repression by microRNA-21. Mol Carcinog 57:536-548
Kanvinde, Shrey; Chhonker, Yashpal Singh; Ahmad, Rizwan et al. (2018) Pharmacokinetics and efficacy of orally administered polymeric chloroquine as macromolecular drug in the treatment of inflammatory bowel disease. Acta Biomater 82:158-170
Payne, William M; Svechkarev, Denis; Kyrychenko, Alexander et al. (2018) The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly. Carbohydr Polym 182:132-141

Showing the most recent 10 out of 1372 publications